Press Releases

Jul 29, 2020

PharmaCyte Biotech Receives CE Mark for Licensed COVID-19 Molecular Tests

Jul 27, 2020

PharmaCyte Biotech Announces Submission of Drug Master File to FDA for Company’s Pancreatic Cancer Therapy

Jul 13, 2020

PharmaCyte Biotech Successfully Completes Container Closure Integrity Test

Jul 8, 2020

PharmaCyte Biotech Successfully Completes Three-Month Stability Study

Jun 23, 2020

PharmaCyte Biotech Provides IND Submission Update for Pancreatic Cancer Clinical Trial

Jun 15, 2020

PharmaCyte Biotech Successfully Accelerates Development of Container Closure Integrity Test for Pancreatic Cancer Clinical Trial Product

Jun 10, 2020

PharmaCyte Biotech Successfully Develops “Change History” for its Clinical Trial Product for Pancreatic Cancer

Jun 8, 2020

PharmaCyte Biotech Completes Final cGMP Audit of Manufacturing Facility for Pancreatic Cancer Clinical Trial Product

May 26, 2020

PharmaCyte Biotech Announces Final Major Study for IND Submission Has Begun

May 11, 2020

PharmaCyte Biotech Conducting Final Audit of Manufacturing Facility after Batch Records Deemed cGMP Compliant